By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nanosphere reported after the close of the market Wednesday that its full-year 2010 revenues declined 9 percent to $2 million from $2.2 million.

The Northbrook, Ill.-based molecular diagnostics developer fell short of analysts' consensus estimate of $2.4 million in revenues for the year.

Its product sales increased to $1.4 million from $1.1 million year over year, while its grant and contract revenue fell to $610,000 from $1.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.